Cantley Lab

You are here

Publications

[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Abbott DW, Yang Y, Hutti JE, Madhavarapu S, Kelliher MA, Cantley LC.  2007.  Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.. Mol Cell Biol. 27(17):6012-25.
Abbott DW, Wilkins A, Asara JM, Cantley LC.  2004.  The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.. Curr Biol. 14(24):2217-27.
Aksoy IA, Ramsey MJ, Fruman DA, Aksoy S, Cantley LC, Tucker JD, Roberts TM.  1999.  Mouse phosphoinositide 3-kinase p110alpha gene: cloning, structural organization, and localization to chromosome 3 band B.. Biochem Biophys Res Commun. 262(2):438-42.
Anaesth BJ.  2013.  Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar.
Anastasiou D, Cantley LC.  2012.  Breathless cancer cells get fat on glutamine.. Cell Res. 22(3):443-6.
Anastasiou D, Yu Y, Israelsen WJ, Jiang J-K, Boxer MB, Hong BSoo, Tempel W, Dimov S, Shen M, Jha A et al..  2012.  Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.. Nat Chem Biol. 8(10):839-47.
Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang J-K, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS et al..  2011.  Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses.. Science. 334(6060):1278-83.
Aramburu J, Yaffe MB, López-Rodríguez C, Cantley LC, Hogan PG, Rao A.  1999.  Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.. Science. 285(5436):2129-33.
Asara JM, Christofk HR, Freimark LM, Cantley LC.  2008.  A label-free quantification method by MS/MS TIC compared to SILAC and spectral counting in a proteomics screen.. Proteomics. 8(5):994-9.
Asara JM, Zhang X, Zheng B, Maroney LA, Christofk HR, Wu N, Cantley LC.  2006.  In-gel stable isotope labeling for relative quantification using mass spectrometry.. Nat Protoc. 1(1):46-51.
Asara JM, Zhang X, Zheng B, Christofk HH, Wu N, Cantley LC.  2006.  In-Gel Stable-Isotope Labeling (ISIL): a strategy for mass spectrometry-based relative quantification.. J Proteome Res. 5(1):155-63.
Asara JM, Garavelli JS, Slatter DA, Schweitzer MH, Freimark LM, Phillips M, Cantley LC.  2007.  Interpreting sequences from mastodon and T. rex.. Science. 317(5843):1324-5.
Asara JM, Schweitzer MH, Freimark LM, Phillips M, Cantley LC.  2007.  Protein sequences from mastodon and Tyrannosaurus rex revealed by mass spectrometry.. Science. 316(5822):280-5.
Auger KR, Serunian LA, Soltoff SP, Libby P, Cantley LC.  1989.  PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells.. Cell. 57(1):167-75.
Auger KR, Cantley LC.  1991.  Novel polyphosphoinositides in cell growth and activation.. Cancer Cells. 3(7):263-70.
Auger KR, Carpenter CL, Shoelson SE, Piwnica-Worms H, Cantley LC.  1992.  Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro.. J Biol Chem. 267(8):5408-15.
Auger KR, Carpenter CL, Cantley LC, Varticovski L.  1989.  Phosphatidylinositol 3-kinase and its novel product, phosphatidylinositol 3-phosphate, are present in Saccharomyces cerevisiae.. J Biol Chem. 264(34):20181-4.
B
Baba Y, Nosho K, Shima K, Meyerhardt JA, Chan AT, Engelman JA, Cantley LC, Loda M, Giovannucci E, Fuchs CS et al..  2010.  Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.. Br J Cancer. 103(7):1025-33.
Bachelot C, Rameh L, Parsons T, Cantley LC.  1996.  Association of phosphatidylinositol 3-kinase, via the SH2 domains of p85, with focal adhesion kinase in polyoma middle t-transformed fibroblasts.. Biochim Biophys Acta. 1311(1):45-52.
Baker R, Lewis SM, Sasaki AT, Wilkerson EM, Locasale JW, Cantley LC, Kuhlman B, Dohlman HG, Campbell SL.  2013.  Site-specific monoubiquitination activates Ras by impeding GTPase-activating protein function.. Nat Struct Mol Biol. 20(1):46-52.
Banko MR, Allen JJ, Schaffer BE, Wilker EW, Tsou P, White JL, Villén J, Wang B, Kim SR, Sakamoto K et al..  2011.  Chemical genetic screen for AMPKα2 substrates uncovers a network of proteins involved in mitosis.. Mol Cell. 44(6):878-92.
Barbour LA, Rahman SMizanoor, Gurevich I, J Leitner W, Fischer SJ, Roper MD, Knotts TA, Vo Y, McCurdy CE, Yakar S et al..  2005.  Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess.. J Biol Chem. 280(45):37489-94.
Barnes KR, Blois J, Smith A, Yuan H, Reynolds F, Weissleder R, Cantley LC, Josephson L.  2008.  Fate of a bioactive fluorescent wortmannin derivative in cells.. Bioconjug Chem. 19(1):130-7.
Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villén J, Li J, Cohn MA, Cantley LC, Gygi SP.  2004.  Large-scale characterization of HeLa cell nuclear phosphoproteins.. Proc Natl Acad Sci U S A. 101(33):12130-5.
Begley MJ, Yun C-H, Gewinner CA, Asara JM, Johnson JL, Coyle AJ, Eck MJ, Apostolou I, Cantley LC.  2015.  EGF-receptor specificity for phosphotyrosine-primed substrates provides signal integration with Src.. Nat Struct Mol Biol.